Novavax, Inc.NVAXNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average, modest growth trend.
Left:
||||
Year-over-year revenue growth rate
Latest
-70.55%
↓ 129% below average
Average (39q)
245.15%
Historical baseline
Range
High:6702.77%
Low:-506.22%
CAGR
+5.1%
Consistent expansion
| Period | Value |
|---|---|
| Q3 2025 | -70.55% |
| Q2 2025 | -64.11% |
| Q1 2025 | 654.89% |
| Q4 2024 | 4.50% |
| Q3 2024 | -79.66% |
| Q2 2024 | 342.69% |
| Q1 2024 | -67.79% |
| Q4 2023 | 1220.44% |
| Q3 2023 | -94.80% |
| Q2 2023 | 6702.77% |
| Q1 2023 | -102.23% |
| Q4 2022 | -60.82% |
| Q3 2022 | 295.09% |
| Q2 2022 | -69.25% |
| Q1 2022 | 183.23% |
| Q4 2021 | -506.22% |
| Q3 2021 | -39.99% |
| Q2 2021 | -33.36% |
| Q1 2021 | 59.92% |
| Q4 2020 | 78.10% |
| Q3 2020 | 341.85% |
| Q2 2020 | 952.35% |
| Q1 2020 | -61.69% |
| Q4 2019 | 251.66% |
| Q3 2019 | -25.32% |
| Q2 2019 | -15.70% |
| Q1 2019 | -35.01% |
| Q4 2018 | -20.79% |
| Q3 2018 | -28.20% |
| Q2 2018 | 11.60% |
| Q1 2018 | -7.29% |
| Q4 2017 | 24.66% |
| Q3 2017 | 24.06% |
| Q2 2017 | 18.52% |
| Q1 2017 | 5.20% |
| Q4 2016 | 67.10% |
| Q3 2016 | 28.98% |
| Q2 2016 | -40.61% |
| Q1 2016 | -27.93% |
| Q4 2015 | -10.30% |